Press release
Cancer Clinical Decision Tools Market Forecast 2024-2033: Size, Drivers, and Emerging Trends
"The Business Research Company recently released a comprehensive report on the Global Cancer Clinical Decision Tools Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.According to The Business Research Company's, The cancer clinical decision tools market size has grown rapidly in recent years. It will grow from $0.45 billion in 2023 to $0.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to growing prevalence of cancer, increasing complexity of cancer treatment, rising demand for personalized medicine, growing adoption of value-based healthcare, increasing availability of cancer data, government support for cancer research and development.
The cancer clinical decision tools market size is expected to see rapidly grown in the next few years. It will grow to $0.72 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to global aging population, patient engagement and shared decision-making, patient-centric care, clinical research and evidence-based medicine. Major trends in the forecast period include advancements in medical imaging, ai-driven clinical decision support, telemedicine and remote consultations, predictive analytics, interoperability and data standards, ethical and regulatory considerations.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report
Market Drivers and Trends:
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision tools market. For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the cancer clinical decision tools market growth.
Major companies operating in the cancer clinical decision tools market are exploring innovative products such as the BenchMark Ultra Plus tissue staining system to gain a competitive advantage. The BenchMark Ultra Plus system optimizes tissue staining for faster and more accurate pathology results. For instance, in June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, launched the BenchMark Ultra Plus tissue staining system, which boasts improved workflow efficiency, testing processes, and sustainability features. This innovative system empowers pathologists to deliver high-quality, time-sensitive results to medical professionals and patients. The BenchMark Ultra Plus system represents the next step in the BenchMark series' evolution, automating previously manual slide-by-slide processes and revolutionizing cancer diagnostics.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3463&type=smp
Major Key Players of the Market:
McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers AG; Elsevier B.V.; Macmillan Publishers Limited; National Decision Support Company; IBM Watson Health; Cerner Corporation; GE Healthcare; Allscripts Healthcare Solutions Inc.; Epic Systems Corporation; Koninklijke Philips N.V.; RaySearch Laboratories AB; Elekta AB; Varian Medical Systems Inc.; Accuray Incorporated; F. Hoffmann-La Roche Ltd.; Flatiron Health Inc.; Tempus Labs Inc.; NantHealth Inc.; Syapse Inc.; Inspirata Inc.; Oncora Medical Inc.; Prognos Health Inc.; Deep 6 AI Inc.; PathAI Inc.; Enlitic Inc.; Ibex Medical Analytics Ltd.; Zebra Medical Vision Ltd.; Aidoc Medical Ltd.
Cancer Clinical Decision Tools Market 2024 Key Insights:
• The cancer clinical decision tools market size will grow to $0.72 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%.
• Rise In Cancer Cases Drives Demand For Cancer Clinical Decision Tools
• Innovative Products Transforming Cancer Clinical Decision Tools Market
• North America was the largest region in the cancer clinical decision tools market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=3463&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
"""Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Clinical Decision Tools Market Forecast 2024-2033: Size, Drivers, and Emerging Trends here
News-ID: 3760015 • Views: …
More Releases from The Business research company

Industrial Gas Market Growth to be Driven by Emerging Trends | $209.86 Billion b …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Industrial Gas Industry?
The size of the industrial gas market has seen substantial growth in the last few years. The market value will increase from $131.46 billion in 2024 to $143.62 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%.…

Global Soil Amendments Market Expansion at 10.5% CAGR, Valued at $7.57 Billion b …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Soil Amendments Market Size Forecast for 2025?
The market size for soil amendments has experienced robust growth in the last few years. It's projected to expand from $4.65 billion in 2024 to $5.09 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The growth…

Chitosan Industry to Achieve $22.39 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Chitosan Market Grow by 2025 in Terms of Size and Growth?
There has been a fast-paced expansion in the chitosan market size over the recent past. The figures are set to increase from $8.65 billion in 2024 to $10.2 billion in 2025, indicating a compound annual growth rate (CAGR)…

Household Cleaning Products Market to Record 9.5% CAGR Growth Through 2029 | Glo …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Household Cleaning Products Market Outlook: How is the Market Expected to Grow by 2025?
The market for household cleaning products has seen notable expansion in the recent past. The market scale is expected to rise from $125.82 billion in 2024 to $134.5 billion in 2025, manifesting a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…